Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Expert Consensus on Nutrition Standards for Intensive Care Units in Resource Limited Settings

14 de novembro de 2026 atualizado por: Vijay Sundarsingh, RESQ Nutri ICU group

International Consensus on Nutritional Practices in Resource-Limited Intensive Care Units: The RES-Q Nutri ICU (REsource-limited Standards & Quality for Nutrition in the ICU) Modified Delphi Consensus Study

The goal of this observational study is to develop practical, expert-agreed standards for nutrition care of critically ill adults in intensive care units (ICUs) in resource-limited settings. The main question it aims to answer is:

Which nutrition practices do international ICU experts agree are essential and achievable for critically ill patients in hospitals with limited resources?

Participants will be ICU doctors, dietitians and nurses with experience of nutrition care in resource-limited settings. They will rate a set of statements across five areas of ICU nutrition in anonymous online survey rounds. After each round they will see a summary of the group's responses and may revise their ratings. A statement reaches agreement when at least 80% of experts agree with it, and rounds will continue until responses stabilise. ICU survivors and family members will also review a plain-language version of the statements, and their feedback will be shared with the expert panel.

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Descrição detalhada

Background: International ICU nutrition guidelines come almost entirely from trials in high-income settings. Lower-middle-income countries contributed less than 1% of patients and low-income countries none. ICUs that lack dietitians, feeding pumps, indirect calorimetry, post-pyloric access, specialised formulas or laboratory monitoring have no agreed minimum standard. This includes ICUs in low- and middle-income countries, remote or public facilities anywhere, and ICUs during surges. "Resource-limited" here is defined by what resources are available, not by World Bank income group.

Design: This is an international, web-based modified Delphi study reported according to ACCORD. A multidisciplinary Steering Committee drafts and refines the statements and analyses responses but does not vote. An independent Delphi methodologist oversees the process to limit bias. Panellists are recruited by purposive sampling through professional networks and societies, aiming for diversity in profession, geography, sex and resource setting.

Statement development: Round 1 statements come from a systematic search of PubMed, Embase, Scopus, Web of Science, Google Scholar and ESPEN, ASPEN and ESICM guidelines, covering adult literature in English from 2015 to 2026. Two reviewers screen in Rayyan and report selection in a PRISMA diagram. Statements are grouped into five domains: screening and assessment; timing, route and delivery; monitoring and metabolic control; micronutrients and special situations; and team, documentation and quality improvement. An evidence summary goes out with Round 1.

Delphi process: Panellists will rate statements on a 9-point scale, give free-text comments and describe the resource limitations in their practice. In later rounds they receive their own previous rating, the group median and IQR, percentage agreement and anonymised comments. A statement is revised when at least 10% of respondents (at least four) raise the same issue, and revisions that change its meaning are re-rated. Rounds continue until responses are stable, and the panel then approves the final set.

Patient involvement: Five to ten ICU survivors or patient representatives take part in single interviews in their preferred language and rate the value of the Round 1 statements. Their views are fed back to the panel but do not count towards consensus.

Analysis: Consensus to include is at least 80% of ratings at 7-9, and consensus to exclude is at least 80% at 1-3. Stability is tested with the Wilcoxon signed-rank test between consecutive rounds. If attrition exceeds 20%, a sensitivity analysis is run. Exploratory comparisons are made by profession and by income setting.

Ethics: Approved by the Institutional Ethics Committee, Father Muller Medical College (FMIEC/CCM/495/2026), with electronic consent from panellists.

Tipo de estudo

Observacional

Inscrição (Estimado)

50

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

    • Karnataka
      • Mangalore, Karnataka, Índia, 575002
        • Father Muller Medical College
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

N/D

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

The study population is an international, multidisciplinary panel of about 40 to 50 professionals with expertise in adult critical care nutrition practice, research, education or guideline development. It includes intensivists, ICU dietitians, critical care nurses, clinical pharmacists, nutrition researchers and allied professionals involved in ICU nutrition. At least 60% of the panel will be from low- and middle-income countries or will have current experience of working in resource-limited ICUs, and at least one-third will be non-physicians. In addition, 5 to 10 adult ICU survivors or patient-care representatives, mainly from resource-limited settings, will take part in patient and public involvement interviews.

Descrição

Inclusion Criteria:

  • Panellists will be eligible if they meet all of the following criteria:

    1. Professional background: Adult ICU clinicians or researchers involved in critical care nutrition practice, research, education, or guideline development, and belonging to one of the following professional groups: intensivists, ICU dietitians, critical care nurses, clinical pharmacists, nutrition researchers, or allied professionals involved in ICU nutrition.

    2. Relevant expertise: At least one of the following:

      1. At least one peer-reviewed publication related to critical care nutrition.
      2. A minimum of 10 years of relevant ICU or nutrition experience, with at least 50% of clinical time spent managing critically ill patients.
      3. Involvement in nutrition guideline or protocol development.
      4. A leadership or advocacy role in a critical care or nutrition society; or
      5. At least 5 years of direct experience working in resource-limited ICU settings.
    3. Willingness to participate: Willingness to participate in multiple Delphi rounds.

    4. Professional diversity: At least one-third of the final panel will comprise non-physicians.

Exclusion Criteria:

  • 1. Failure to provide implied consent through survey participation. 2. Inability to comprehend or independently vote on statements written in English. (To support non-native English speakers, all Delphi statements will be written in clear, unambiguous English.) 3. Incomplete Round 1 response with no rating data.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Modelos de observação: OTHER
  • Perspectivas de Tempo: PROSPECTIVE

Coortes e Intervenções

Grupo / Coorte
Expert Delphi Panel

International multidisciplinary panel of approximately 40 to 50 experts in adult critical care nutrition, including intensivists, ICU dietitians, critical care nurses, clinical pharmacists and nutrition researchers.At least 60% will be from low- and middle-income countries or resource-limited ICUs, and at least one-third will be non-physicians. Panellists will rate draft statements on minimum nutrition standards over iterative anonymous online rounds until consensus and stability are reached.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
To establish consensus-based minimum standards for assessment, initiation, delivery, and monitoring of nutritional therapy in resource-limited ICUs.
Prazo: Through study completion, an average of 18 months

Number and proportion of Delphi statements reaching consensus to include (at least 80% of panellists rating 7 to 9 on a 9-point Likert scale) or consensus to exclude (at least 80% rating 1 to 3), with response stability between consecutive rounds (no significant variation on the Wilcoxon signed-rank or Kruskal-Wallis test, p of 0.05 or more). For each statement, the median, interquartile range and percentage agreement will be reported.

Through study completion, an average of 18 months

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
To identify pragmatic adaptations of existing international ICU nutrition guidelines for resource-limited settings.
Prazo: Through study completion, an average of 18 months

Number and proportion of statements describing adaptations of ESPEN, ASPEN or ESICM recommendations that reach consensus to include (at least 80% rating 7 to 9) with response stability.

Through study completion, an average of 18 months
To identify essential (minimum) nutritional practices for critically ill patients in ICUs
Prazo: Through study completion, an average of 18 months

Number and proportion of statements rated "essential" (7 to 9) by at least 80% of panellists with response stability, reported for each of the five domains.

Through study completion, an average of 18 months
To identify research priorities in ICU nutrition for resource-limited settings.
Prazo: Through study completion, an average of 18 months

Research priorities identified from statements reaching no consensus after repeated rating, and from themes in panellists' free-text comments, analysed thematically.

Through study completion, an average of 18 months

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Vijay Sundarsingh, MD,DM, Father Muller Medical College
  • Investigador principal: Soumaya Touzani, MD, PhD, Hassan II University Hospital
  • Investigador principal: Prashant Nasa, MD,FNB, University Hospital Plymouth NHS Trust, Plymouth, UK

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de janeiro de 2027

Conclusão Primária (Estimado)

31 de dezembro de 2027

Conclusão do estudo (Estimado)

30 de junho de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

9 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

14 de novembro de 2026

Primeira postagem (Real)

19 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

19 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

14 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • FMIEC/CCM/495/2026

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Individual participant data will not be shared. Participants consented to their responses being reported only in aggregate, and the small expert panel carries a risk of re-identification. Aggregate results for each statement will be published in the final manuscript.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .